ATE405583T1 - Human kinase interacting protein 2 (kip2)-related gene variant (kip2v1) im zusammenhang mit prostatakrebs - Google Patents

Human kinase interacting protein 2 (kip2)-related gene variant (kip2v1) im zusammenhang mit prostatakrebs

Info

Publication number
ATE405583T1
ATE405583T1 AT05011950T AT05011950T ATE405583T1 AT E405583 T1 ATE405583 T1 AT E405583T1 AT 05011950 T AT05011950 T AT 05011950T AT 05011950 T AT05011950 T AT 05011950T AT E405583 T1 ATE405583 T1 AT E405583T1
Authority
AT
Austria
Prior art keywords
kip2v1
kip2
prostate cancer
gene variant
related gene
Prior art date
Application number
AT05011950T
Other languages
English (en)
Inventor
Ken-Shwo Dai
Original Assignee
Bioptik Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioptik Tech Inc filed Critical Bioptik Tech Inc
Application granted granted Critical
Publication of ATE405583T1 publication Critical patent/ATE405583T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
AT05011950T 2005-06-02 2005-06-02 Human kinase interacting protein 2 (kip2)-related gene variant (kip2v1) im zusammenhang mit prostatakrebs ATE405583T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05011950A EP1728799B1 (de) 2005-06-02 2005-06-02 Human Kinase interacting Protein 2 (KIP2)-related gene variant (KIP2V1) im Zusammenhang mit Prostatakrebs

Publications (1)

Publication Number Publication Date
ATE405583T1 true ATE405583T1 (de) 2008-09-15

Family

ID=34937190

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05011950T ATE405583T1 (de) 2005-06-02 2005-06-02 Human kinase interacting protein 2 (kip2)-related gene variant (kip2v1) im zusammenhang mit prostatakrebs

Country Status (3)

Country Link
EP (1) EP1728799B1 (de)
AT (1) ATE405583T1 (de)
DE (1) DE602005009154D1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4271145A (en) 1979-10-22 1981-06-02 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
AU2001241541A1 (en) * 2000-02-17 2001-08-27 Millennium Predictive Medicine, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
US20030190622A1 (en) 2002-03-21 2003-10-09 Ken-Shwo Dai Human kinase interacting protein 2 (KIP2)-related gene variant associated with lung cancers

Also Published As

Publication number Publication date
EP1728799A1 (de) 2006-12-06
EP1728799B1 (de) 2008-08-20
DE602005009154D1 (de) 2008-10-02

Similar Documents

Publication Publication Date Title
DK1218509T3 (da) Fibroblast vækstfaktorlignende polypeptider
WO2004092405A3 (en) Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
RS20170595A1 (sr) Tretman sa anti-vegf antitelima
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
WO2001072957A3 (en) Fibroblast growth factor-like molecules and uses thereof
ATE456579T1 (de) Angiopoietin-like 4 protein hemmer kombinationen und deren verwendung
WO2004110345A8 (en) Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
WO2002029086A3 (en) Nucleic acid sequences differentially expressed in cancer tissue
AR026946A1 (es) Osteoprotegerina/receptores de factores de necrosis de tumores
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
WO2002088750A3 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
TW200716764A (en) Bladder cancer biomarkers and uses thereof
WO2004047623A3 (en) Methods for identifying risk of breast cancer and treatments thereof
DK1536006T3 (da) Cancerantigener og anvendelse deraf
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
ATE405583T1 (de) Human kinase interacting protein 2 (kip2)-related gene variant (kip2v1) im zusammenhang mit prostatakrebs
WO2004083241A3 (en) Btc-interacting proteins and use thereof
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
ATE362535T1 (de) Mutiertes cyclin g1 protein
WO2005014804A3 (en) Ubiquitin-specific protease
WO2005114216A3 (en) Stamp2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
EP1566386A4 (de) Gen in zusammenhang mit haarausfall, das davon kodierte polypeptid und anwendungen dafür
WO2006029005A3 (en) Promoter substitution for immunoglobulin therapy
WO2005118834A3 (en) Methods for identifying risk of breast cancer and treatment thereof
WO2004058167A3 (en) Breast specific protein expressed in cancer and methods of use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties